Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liprodicaine cream versus compound lidocaine cream for topical anesthesia during facial freckle removal or fractional laser treatment
ChiCTR2400094240Phase 4Not yet recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of liprodicaine and lidocaine in severe cutaneous adverse reactions (SCAR) (4 arms), sponsored by The Second Xiangya Hospital. Primary endpoint: Incidence and severity of adverse reactions. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
liprodicainelidocaine
03
Conditions
severe cutaneous adverse reactions (SCAR)
Beyond the preview
Go deeper on ChiCTR2400094240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094240.